Cargando…
A complex systems view on the current hypotheses of epilepsy pharmacoresistance
Drug‐resistant epilepsy remains to this day as a highly prevalent condition affecting around one‐third of patients with epilepsy, despite all the research and the development of several new antiseizure medications (ASMs) over the last decades. Epilepsies are multifactorial complex diseases, commonly...
Autores principales: | Servilha‐Menezes, Gabriel, Garcia‐Cairasco, Norberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340300/ https://www.ncbi.nlm.nih.gov/pubmed/35253410 http://dx.doi.org/10.1002/epi4.12588 |
Ejemplares similares
-
Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?
por: Czornyj, Liliana, et al.
Publicado: (2021) -
Multi‐omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy
por: Bruxel, Estela M., et al.
Publicado: (2021) -
Genetic variations associated with pharmacoresistant epilepsy
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2020) -
Introduction to the special issue “Redesigning the hypotheses for drug‐resistant epilepsy”
por: Rocha, Luisa
Publicado: (2022) -
Cortical stimulation in pharmacoresistant focal epilepsies
por: Ellrich, Jens
Publicado: (2020)